Research, cases and webinars in tricuspid interventions

Launch the video to hear Marianna Adamo and Marta Sitges share how they and Julien Dreyfus strengthened the Leadership team at the end of last year, bringing welcome support to founders Francesco Maisano and Fabien Praz.
 
They explain their individual roles among the PCR Tricuspid Focus Group;...

Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

Julien Dreyfus and Fabien Praz discuss the mission of the PCR Tricuspid Focus Group, aimed at consolidating knowledge on tricuspid valve regurgitation. The main goal is to define future directions and establish best practices to ensure optimal patient care.

This interview was filmed at PCR London Valves...

Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...

Want to take your tricuspid TEER skills to the next level? Watch this video!

You’ll discover how to tackle common anatomical challenges, improve your imaging techniques with tools like intra-cardiac echocardiography and learn expert strategies for managing complex cases. Don't miss these valuable tips and tricks!

The take-home message for clinicians is that in the treatment of tricuspid regurgitation, the most frequent valvular disease alongside aortic stenosis, redefining procedural success as a function of the residual degree of TR is crucial.

This session, in collaboration with the PCR Tricuspid Focus Group, aims to provide a comprehensive understanding of how to image the atrioventricular valves (mitral and tricuspid) to assess their anatomy and pathology. It covers the step-by-step evaluation of the mitral and tricuspid valves using transesophageal echocardiography...

This study highlights the TRISCORE's role in assessing risk for patients undergoing TTVI. Despite limitations, TRISCORE effectively identifies high-risk patients, aiding decision-making in a complex landscape of valvular heart disease management.

This study, based on the trial inclusion and exclusion criteria, aimed to compare outcomes in a contemporary “real-world” T-TEER cohort stratified by TRILUMINATE eligibility or ineligibility.

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video, you will:

• appreciate the challenges in patient assessment 
• understand the need for adjunctive treatment targets
• acknowledge challenges in multivalvular disease

1. Disease stages: criteria of futility and optimal response
2. RV...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• the theoretical implications of TR reduction for RV performance
• the clinical implications of TR reduction for biventricular performance

Implications of TTVI

Previous episode

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn about:

• the data supporting prognostic implications of interventional TR reduction
• the prognostic value of hemodynamic factors
• the importance of central venous congestion

1. Mortality and HF Hospitalization: Prognostic Benefit of Intervention...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• to recall the unique physiology of right ventricular function
• to understand the implications of RV pressure and volume load using the pressure-volume-loop framework
• to illustrate the...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure, starting in this first episode with the hemodynamic assessment.
In this video you will learn:

• to recognize the intricate relationship between symptoms and hemodynamics in (TR-related) right heart failure.
• to...

In this series of tutorials, Karl-Philipp Rommel (Leipzig, Germany) shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

Take inspiration from the discussions on the case of a 78-year-old patient with HTN, HLD, and AF, presenting with symptomatic heart failure, or that of a 59-year-old female patient, former smoker, with HTN, DM, and persistent AF, who had been treated for breast carcinoma and post-chemotherapy...

Join this session to delve into the incidence, outcomes, and survival of patients experiencing tricuspid regurgitation following lead placement. Explore contemporary outcomes of transcatheter edge-to-edge repair for lead-related tricuspid regurgitation, and gain insights into imaging assessment approaches for this condition.

This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...